-
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
-
2023-504922-20-00
5
2024-08-23
Hypercholesterolemia
-
2023-507749-27-00
6
2024-08-16
Hemophilia A
-
2023-505423-31-00
5
2024-08-08
advanced or metastatic gastric adenocarcinoma, gastroesophageal juncti
-
2023-506876-28-00
5
2024-08-01
The medical condition we are investigating is type 1 AMI (STEMI and NS
-
2023-510178-15-00
5
2024-07-31
High-risk Large B-cell Lymphoma
-
2023-503923-24-00
5
2024-07-22
Sjögren’s Syndrome With Moderate-toSevere Symptom State
-
2023-508256-19-00
9
2024-07-15
Unresectable Metastatic Non-small Cell Lung Cancer
-
2023-506457-38-00
5
2024-06-05
Chronic kidney disease (CKD) and hypertension.
-
2023-508359-38-00
5
2024-06-05
Early-stage Non-squamous Non-small Cell Lung Cancer
-
2023-508630-34-00
5
2024-05-28
Overweight
-
2023-506669-70-00
5
2024-04-30
Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM).
-
2023-508456-18-00
6
2024-04-29
Uncomplicated bacteremia caused by E. faecalis or E. faecium.
-
2023-505863-35-00
4
2024-03-20
EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer
-
2023-503827-25-01
5
2024-02-16
Non-Small Cell Lung Cancer (NSCLC)
-
2023-503575-21-00
5
2024-01-23
Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
-
2023-504384-16-00
4
2023-12-18
lung transplant patients (D+/R-)
-
2022-502975-45-00
5
2023-12-12
Metastatic leiomyosarcoma
-
2024-512573-27-01
4
2023-12-11
Muscle-invasive bladder cancer (MIBC)
-
2023-505976-31-00
5
2023-11-24
Systemic Sclerosis (SSc) presenting with Limited or Diffuse Cutaneous
-
2023-503655-10-00
5
2023-11-20
Systemic Lupus Erythematosus (SLE).
-
2023-505107-24-00
9
2023-11-14
Non-small cell lung cancer
-
2022-501863-41-00
5
2023-11-13
Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non–Small
-
2022-502966-26-01
5
2023-10-27
Sjögren’s syndrome